Citation Impact
Citing Papers
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
2018
Sirtuin 3 (SIRT3) Regulates α-Smooth Muscle Actin (α-SMA) Production through the Succinate Dehydrogenase-G Protein-coupled Receptor 91 (GPR91) Pathway in Hepatic Stellate Cells
2016
Energy balance regulation by thyroid hormones at central level
2013
Progress and challenges in anti-obesity pharmacotherapy
2017
Microbial tryptophan catabolites in health and disease
2018 Standout
Mechanisms of hepatic stellate cell activation
2017 Standout
MC4R Agonists: Structural Overview on Antiobesity Therapeutics
2018 StandoutNobel
Regulation and Functions of the ER-Associated Nrf1 Transcription Factor
2022 StandoutNobel
GPCR-Mediated Signaling of Metabolites
2017
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
2018 Standout
The gut–brain axis in obesity
2014
An atlas of O-linked glycosylation on peptide hormones reveals diverse biological roles
2020
The Global Epidemic of the Metabolic Syndrome
2018 Standout
How May GIP Enhance the Therapeutic Efficacy of GLP-1?
2020
Suppression of TLR4 activation by resveratrol is associated with STAT3 and Akt inhibition in oxidized low-density lipoprotein-activated platelets
2018
Toward a new STATe: The role of STATs in mitochondrial function
2014
The sexual dimorphism of obesity
2015
Gut-Brain Cross-Talk in Metabolic Control
2017
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
AMPK, insulin resistance, and the metabolic syndrome
2013
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Non-alcoholic fatty liver disease
2021 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain
2020 StandoutNobel
Self-consumption: the interplay of autophagy and apoptosis
2014 Standout
Role of metabolic programming in the modulation of microglia phagocytosis by lipids
2018
Therapeutic Landscape for NAFLD in 2020
2020
Pyroptosis: A new frontier in cancer
2019 Standout
Hallmarks of Cellular Senescence
2018 Standout
Animal models of obesity and diabetes mellitus
2018
An update on the pathophysiology of osteoarthritis
2016 Standout
The role of senescent cells in ageing
2014 StandoutNature
Geroscience: Linking Aging to Chronic Disease
2014 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
The Hallmarks of Aging
2013 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Blaming the Brain for Obesity: Integration of Hedonic and Homeostatic Mechanisms
2017
European Guidelines for Obesity Management in Adults
2015 Standout
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells
2015
Cellular senescence: from physiology to pathology
2014 Standout
Wound repair and regeneration: Mechanisms, signaling, and translation
2014 Standout
Glycoproteomics
2022 StandoutNobel
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Metabolic control of cell death
2014 Science
Pharmacological Approaches in the Treatment and Maintenance of Weight Loss
2016
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Endoplasmic reticulum-associated SKN-1A/Nrf1 mediates a cytoplasmic unfolded protein response and promotes longevity
2019 StandoutNobel
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
The Caenorhabditis elegans ARIP-4 DNA helicase couples mitochondrial surveillance to immune, detoxification, and antiviral pathways
2022 StandoutNobel
Use of CRISPR/Cas9-engineered INS-1 pancreatic β cells to define the pharmacology of dual GIPR/GLP-1R agonists
2016
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Spermidine in health and disease
2018 StandoutScience
Thyroid Hormone Regulation of Metabolism
2014 Standout
A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2: A Bivalent Advantage
2017
The Science of Obesity Management: An Endocrine Society Scientific Statement
2018
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Biomedical applications of nano-titania in theranostics and photodynamic therapy
2015
Hypothalamic circuits regulating appetite and energy homeostasis: pathways to obesity
2017
Obesity: global epidemiology and pathogenesis
2019 Standout
Works of Brian Finan being referenced
Fibroblast activation protein (FAP) as a novel metabolic target
2016
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
2018
Dual melanocortin‐4 receptor and GLP ‐1 receptor agonism amplifies metabolic benefits in diet‐induced obese mice
2015
Selection and progression of unimolecular agonists at the GIP, GLP-1, and glucagon receptors as drug candidates
2019
Unimolecular Polypharmacy for Treatment of Diabetes and Obesity
2016
GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
2014
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
2018
GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight
2016
Hypothalamic PGC-1α Protects Against High-Fat Diet Exposure by Regulating ERα
2014
Current and Emerging Treatment Options in Diabetes Care
2015
Reappraisal of GIP Pharmacology for Metabolic Diseases
2016
Emerging opportunities for the treatment of metabolic diseases: Glucagon-like peptide-1 based multi-agonists
2015
GLP-1/Glucagon Coagonism Restores Leptin Responsiveness in Obese Mice Chronically Maintained on an Obesogenic Diet
2013
The New Biology and Pharmacology of Glucagon
2017
Sirtuin 1 and Sirtuin 3: Physiological Modulators of Metabolism
2012